Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2019
Colony-Stimulating Factor-1 Antibody Lacnotuzumab in a Phase 1 Healthy Volunteer Study and Mechanistic Investigation of Safety Outcomes
Francois Pognan, Philippe Couttet, Ivan Demin, et al.
Leukemia Research
|
December 7, 2010
Preclinical evaluation of potential nilotinib cardiotoxicity
Armin Wolf, Philippe Couttet, Min Dong, et al.
Plos One
|
April 2, 2011
Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice
Harri Lempiäinen, Arne Müller, Sarah Brasa, et al.
Journal of Medicinal Chemistry
|
January 24, 2018
Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo
Juraj Velcicky, Ursula Bodendorf, Pascal Rigollier, et al.
BMC Biotechnology
|
February 3, 2018
Two approaches for estimating the lower limit of quantitation (LLOQ) of microRNA levels assayed as exploratory biomarkers by RT-qPCR
Russell D Wolfinger, Sudheer Beedanagari, Eric Boitier, et al.
Leukemia Research
|
February 4, 2010
Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies
Armin Wolf, Philippe Couttet, Min Dong, et al.
Plos One
|
August 4, 2012
Perturbation of microRNAs in rat heart during chronic doxorubicin treatment
Caterina Vacchi-Suzzi, Yasmina Bauer, Brian R Berridge, et al.
Science (New York, N.Y.)
|
April 28, 2007
Requirement of bic/microRNA-155 for normal immune function
Antony Rodriguez, Elena Vigorito, Simon Clare, et al.
Critical Reviews in Toxicology
|
May 26, 2021
Methodological considerations for measuring biofluid-based microRNA biomarkers
Brian N Chorley, Elnaz Atabakhsh, Graeme Doran, et al.
Frontiers in Immunology
|
July 9, 2019
Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus Monkeys
Diethilde Theil, Paul Smith, Catherine Huck, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2019
Colony-Stimulating Factor-1 Antibody Lacnotuzumab in a Phase 1 Healthy Volunteer Study and Mechanistic Investigation of Safety Outcomes
Francois Pognan, Philippe Couttet, Ivan Demin, et al.
Leukemia Research
|
December 7, 2010
Preclinical evaluation of potential nilotinib cardiotoxicity
Armin Wolf, Philippe Couttet, Min Dong, et al.
Plos One
|
April 2, 2011
Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice
Harri Lempiäinen, Arne Müller, Sarah Brasa, et al.
Journal of Medicinal Chemistry
|
January 24, 2018
Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo
Juraj Velcicky, Ursula Bodendorf, Pascal Rigollier, et al.
BMC Biotechnology
|
February 3, 2018
Two approaches for estimating the lower limit of quantitation (LLOQ) of microRNA levels assayed as exploratory biomarkers by RT-qPCR
Russell D Wolfinger, Sudheer Beedanagari, Eric Boitier, et al.
Leukemia Research
|
February 4, 2010
Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies
Armin Wolf, Philippe Couttet, Min Dong, et al.
Plos One
|
August 4, 2012
Perturbation of microRNAs in rat heart during chronic doxorubicin treatment
Caterina Vacchi-Suzzi, Yasmina Bauer, Brian R Berridge, et al.
Science (New York, N.Y.)
|
April 28, 2007
Requirement of bic/microRNA-155 for normal immune function
Antony Rodriguez, Elena Vigorito, Simon Clare, et al.
Critical Reviews in Toxicology
|
May 26, 2021
Methodological considerations for measuring biofluid-based microRNA biomarkers
Brian N Chorley, Elnaz Atabakhsh, Graeme Doran, et al.
Frontiers in Immunology
|
July 9, 2019
Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus Monkeys
Diethilde Theil, Paul Smith, Catherine Huck, et al.
Page
of 3